Pancreatic Cancer Research

ResearcherZhengzhou UniversityNo recent work listed

Feng Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0985-980X; OpenAlex author ID A5101732712. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p. Last author DOI 10.3389/fonc.2020.620550↗
  2. Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling. Co-author DOI 10.3892/ol.2016.4761↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Han-Xiao Nie · 1 shared paper, 2020 · strength 0.13
  2. Baishun Wan · 1 shared paper, 2020 · strength 0.13
  3. Ling Zhang · 1 shared paper, 2020 · strength 0.13
  4. Li Wang · 1 shared paper, 2020 · strength 0.13
  5. Yi Zhou · 1 shared paper, 2016 · strength 0.07
  6. Jinxue Zhou · 1 shared paper, 2016 · strength 0.07
  7. Nanmu Yang · 1 shared paper, 2016 · strength 0.07
  8. Tao Huang · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.